Intralytix is a pioneering biotechnology company based in Columbia, MD, specializing in the development and commercialization of bacteriophage-based products. Bacteriophages, or phages, are viruses that specifically target and kill bacteria, offering a natural and highly effective solution for bacterial contamination. The company operates primarily in the food safety and human health markets, providing products that enhance food processing safety, prevent food spoilage, and treat bacterial infections in both humans and animals.

Intralytix serves a diverse range of clients, including food processors, agricultural businesses, and healthcare providers. The company's business model revolves around the research, development, and sale of bacteriophage products. Revenue is generated through direct sales of these products, as well as through partnerships and licensing agreements with other companies in the biotechnology and healthcare sectors.

The market for bacteriophage-based solutions is growing, driven by increasing concerns over antibiotic resistance and the demand for safer, more natural antimicrobial treatments. Intralytix is well-positioned to capitalize on this trend, leveraging its expertise in phage technology to offer innovative and effective solutions.

Keywords: bacteriophage, food safety, human health, biotechnology, antimicrobial, bacterial control, phage therapy, food processing, agricultural applications, healthcare solutions.